Liao, L.* ; Han, W. ; Shen, Y.* & Shen, G.* Comprehensive analysis of aberrantly methylated differentially expressed genes and validation of CDC6 in melanoma. J. Cancer Res. Clin. Oncol. 150:362 (2024)
Heinrich, K.* et al. Lessons learned: The first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board. J. Cancer Res. Clin. Oncol., DOI: 10.1007/s00432-022-04165-0 (2022)
Regel, I.* et al. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations. J. Cancer Res. Clin. Oncol. 146, 1153-1167 (2020)
Budau, L.* et al. Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: A secondary analysis of a randomized clinical trial. J. Cancer Res. Clin. Oncol. 145, 2149-2156 (2019)
Haen, S.P.* et al. Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies. J. Cancer Res. Clin. Oncol. 143, 759-771 (2017)
Heindl, S.* et al. Relevance of MET activation and genetic alterations of KRAS and E-cadherin for cetuximab sensitivity of gastric cancer cell lines. J. Cancer Res. Clin. Oncol. 138, 843-858 (2012)
Werner, M.* ; Becker, K.F.* ; Keller, G.* & Höfler, H. Gastric adenocarcinoma : Pathomorphology and molecular pathology. J. Cancer Res. Clin. Oncol. 127, 207-216 (2001)
Eichholtz-Wirth, H. ; Born, R. ; Reidel, G.* & Hietel, B. Transient cisplatin-resistant murine fibrosarcoma cell characterized by increased metallothionein content. J. Cancer Res. Clin. Oncol. 119, 227-233 (1993)
Issels, R.D. et al. Improvement of Local Control by Regional Hyperthermia Combined with Systemic  Chemotherapy (ifosfamide plus etoposide) in advanced Sarcomas: Updated Report on 65 Patients. J. Cancer Res. Clin. Oncol. 117 (Suppl.IV), 141-147 (1991)
Mezger, J. Letter to the editors. J. Cancer Res. Clin. Oncol. 117, 502 (1991)
Hueltner, L. ; Welle, M. ; Strauss, P.G. ; Moeller, J. & Doermer, P. Consecutive Stages on Neoplastic Transformation in Mouse Bone Marro-derived Mast Cells. J. Cancer Res. Clin. Oncol. (1990)
Polack, A. ; Hergenhan, M. ; Kloz, U. ; Hecker, E. & Bornkamm, G.W. Description of an EBV Derived System Detecting Tumorpromoters of the Diterpene Ester Type with High Sensitivity. J. Cancer Res. Clin. Oncol. (1990)
Zimber-Strobl, U. et al. Analysis of EBV-terminal Protein Gene Expression Provides Evidence for Integration of Viral DNA Into the Host Genome in Burkitt Lymphoma and Nasapharyngeal Carcinoma Cells. J. Cancer Res. Clin. Oncol. (1990)
Luz, A. & Murray, A.B. Sudden outbreak of a leukemia-like lesion in female CBA mice after repeated injections of 5-azacytidine. J. Cancer Res. Clin. Oncol. 114, 525-527 (1988)
Thomale, J.* ; Luz, A. & Nass, G.S.* Excretion of modified nucleosides during development of malignant lymphomas in mice after whode body irradiation. J. Cancer Res. Clin. Oncol. 108, 302-307 (1984)
Marquart, K.H. Intranuclear vermicellar bodies in human osteosarcoma and ossifying fibroma cells. J. Cancer Res. Clin. Oncol. 106, 74-76 (1983)
Oesterle, D. & Deml, E. Promoting effect of polychlorinated biphenyls on development of enzyme-altered islands in livers of weanling and adult rats. J. Cancer Res. Clin. Oncol. 105, 141-147 (1983)
Schmahl, W.G. & Kriegel, H. Ovary tumors in NMRI mice subjected to fractionated X-irradiation during fetal development. J. Cancer Res. Clin. Oncol. 98, 65-74 (1980)
Schmahl, W.G. ; Kriegel, H. & Senft, E. Can prenatal X-irradiation in mice act as an initiator stimulus in a modified 2-stage Berenblum/Mottram experiment with postnatal promotion with phorbol ester TPA?. J. Cancer Res. Clin. Oncol. 97, 109-117 (1980)
Erfle, V. ; Schulte-Overberg, S. ; Marquart, K.H. ; Adler, I.-D. & Luz, A. Establishment and characterization of C-type RNA virus-producing cell lines from radiation-induced murine osteosarcomas. J. Cancer Res. Clin. Oncol. 94, 149-162 (1979)